You are being a little harsh on them because they have actually exceeded 10% pa compound NPAT growth but the change to AASB15 in FY19 meant their reported NPAT took a hit (FY18 NPAT was restated from $16.4m to $12.6m) and subsequent years of FY19 and FY20 grow off that lower base.
Reported NPAT growth each year since 2015 (ignoring the AASB15 change) is -5%, 17%, 13%, 14%, 13%.
A better way to gauge the compound growth is to look at the operating cash flow. It has grown from $10.9m to $19.4m, growth of 12% pa since 2015
Ann: AGM Presentation 2020, page-9
Add FSA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $109.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 89.0¢ | 89150 | 1 |
View Market Depth
| Last trade - 16.12pm 30/08/2024 (20 minute delay) ? |
| FSA (ASX) Chart |
Day chart unavailable